Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Développement des médicaments en pédiatrie : défis existants et recommandations.
Kaguelidou F, Ouèdraogo M, Treluyer JM, Le Jeunne C, Annereau M, Blanc P, Bureau S, Ducassou S, Fiquet B, Flamein F, Gaillard S, Hankard R, Laugel V, Laurent C, Levy C, Marquet T, Polak M, Portefaix A, Vassal G. Kaguelidou F, et al. Among authors: treluyer jm. Therapie. 2023 Jan-Feb;78(1):95-104. doi: 10.1016/j.therap.2022.12.002. Epub 2022 Dec 5. Therapie. 2023. PMID: 36543724 French. No abstract available.
Paediatric drug development and evaluation: Existing challenges and recommendations.
Kaguelidou F, Ouèdraogo M, Treluyer JM, Le Jeunne C, Annereau M, Blanc P, Bureau S, Ducassou S, Fiquet B, Flamein F, Gaillard S, Hankard R, Laugel V, Laurent C, Levy C, Marquet T, Polak M, Portefaix A, Vassal G. Kaguelidou F, et al. Among authors: treluyer jm. Therapie. 2023 Jan-Feb;78(1):105-114. doi: 10.1016/j.therap.2022.11.010. Epub 2022 Dec 5. Therapie. 2023. PMID: 36528416
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.
Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, Polard E, Burgun A, Treluyer JM, Neuraz A; AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium”. Chouchana L, et al. Among authors: treluyer jm. Cardiovasc Drugs Ther. 2022 Jun;36(3):483-488. doi: 10.1007/s10557-021-07155-5. Epub 2021 Feb 17. Cardiovasc Drugs Ther. 2022. PMID: 33595761 Free PMC article.
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Detroit M, Collier M, Beeker N, Willems L, Decroocq J, Deau-Fischer B, Vignon M, Birsen R, Moufle F, Leclaire C, Balladur E, Deschamps P, Chauchet A, Batista R, Limat S, Treluyer JM, Ricard L, Stocker N, Hermine O, Choquet S, Morel V, Metz C, Bouscary D, Kroemer M, Zerbit J. Detroit M, et al. Among authors: treluyer jm. Cancers (Basel). 2023 Aug 9;15(16):4028. doi: 10.3390/cancers15164028. Cancers (Basel). 2023. PMID: 37627056 Free PMC article.
Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France.
Hoertel N, Sánchez-Rico M, de la Muela P, Abellán M, Blanco C, Leboyer M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, Becker KA, Vernet R, Beeker N, Neuraz A, Alvarado JM, Herrera-Morueco JJ, Airagnes G, Lemogne C, Limosin F; AP-HP/Université de Paris/Inserm COVID-19 Research Collaboration and the AP-HP COVID CDR Initiative, “Entrepôt de Données de Santé,” AP-HP Consortium. Hoertel N, et al. Biol Psychiatry Glob Open Sci. 2023 Jan;3(1):56-67. doi: 10.1016/j.bpsgos.2021.12.007. Epub 2022 Jan 4. Biol Psychiatry Glob Open Sci. 2023. PMID: 35013734 Free PMC article.
Quantification of maternal and fetal valaciclovir exposure in a pharmacokinetic study of cytomegalovirus-infected pregnant women treated to prevent vertical transmission.
Faure-Bardon V, Bouazza N, Benaboud S, Foissac F, Rouillon S, Froelicher-Bournaud L, Leruez-Ville M, Guilleminot T, Lui G, Tréluyer JM, Ville Y. Faure-Bardon V, et al. Among authors: treluyer jm. J Antimicrob Chemother. 2025 Jan 15:dkae470. doi: 10.1093/jac/dkae470. Online ahead of print. J Antimicrob Chemother. 2025. PMID: 39810739
A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM study protocol.
Luu M, Vabres P, Espitalier A, Maurer A, Garde A, Racine C, Carpentier M, Rega A, Loffroy R, Hadouiri N, Boddaert N, Curie A, Guibaud L, Chebbi M, Charligny J, Kuentz P, Canaud G, Bahi-Buisson N, Fleck C, Cransac A, Bardou M, Faivre L; SESAM study group. Luu M, et al. BMJ Open. 2024 Dec 20;14(12):e084614. doi: 10.1136/bmjopen-2024-084614. BMJ Open. 2024. PMID: 39806603 Free PMC article. Clinical Trial.
412 results